Associations of race and ethnicity with anemia management among patients initiating renal replacement therapy - PubMed (original) (raw)
. 2007 Nov;99(11):1218-26.
Affiliations
- PMID: 18020096
- PMCID: PMC2574315
Associations of race and ethnicity with anemia management among patients initiating renal replacement therapy
Steven D Weisbord et al. J Natl Med Assoc. 2007 Nov.
Abstract
Background: Many patients initiate renal replacement therapy with suboptimal anemia management. The factors contributing to this remain largely unknown. The aim of this study was to assess the associations of race and ethnicity with anemia care prior to the initiation of renal replacement therapy.
Methods: Using data from the medical evidence form filed for patients who initiated renal replacement therapy between 1995-2003, we assessed racial and ethnic differences in pre-end-stage renal disease hematocrit levels, the use of erythropoiesis stimulation agents (ESAs), the proportion of patients with hematocrit levels > or = 33% and the proportion of patients with hematocrit levels < 33% that did not receive ESA. We also examined secular trends in racial and ethnic differences in these parameters.
Results: In multivariable analyses, non-Hispanic blacks had lower hematocrit levels (delta hematocrit = -0.97%, 95% CI: -1.00-0.94%), and were less likely to receive ESA (OR = 0.82, 95% CI: 0.81-0.84), to initiate renal replacement therapy with hematocrit > or = 33% (OR = 0.78, 95% CI: 0.77-0.79) or to receive ESA if the hematocrit was < 33% (OR = 0.79, 95% CI: 0.77-0.80) than non-Hispanic whites. White Hispanics also had lower hematocrit levels (delta hematocrit = -0.42%, 95% CI:-0.47% to -0.37%), and were less likely to receive ESA (OR = 0.86, 95% CI: 0.85-0.88), to have hematocrit levels > or = 33% (OR = 0.91, 95% CI: 0.89-0.93) or to receive ESA if the hematocrit was < 33% (OR = 0.85, 95% CI: 0.83-0.87) than non-Hispanic whites. These disparities persisted over the eight-year study period.
Conclusions: African-American race and Hispanic ethnicity are associated with suboptimal pre-end-stage renal disease anemia management. Efforts to improve anemia care should incorporate targeted interventions to decrease these disparities.
Similar articles
- Intermediate outcomes by race and ethnicity in peritoneal dialysis patients: results from the 1997 ESRD Core Indicators Project. National ESRD Core Indicators Workgroup.
Rocco MV, Frankenfield DL, Frederick PR, Pugh J, McClellan WM, Owen WF. Rocco MV, et al. Perit Dial Int. 2000 May-Jun;20(3):328-35. Perit Dial Int. 2000. PMID: 10898051 - Laboratory abnormalities at the onset of treatment of end-stage renal disease: are there racial or socioeconomic disparities in care?
Ward MM. Ward MM. Arch Intern Med. 2007 May 28;167(10):1083-91. doi: 10.1001/archinte.167.10.1083. Arch Intern Med. 2007. PMID: 17533212 - Racial and Ethnic Disparities in Kidney Replacement Therapies Among Adults With Kidney Failure: An Observational Study of Variation by Patient Age.
Wilk AS, Cummings JR, Plantinga LC, Franch HA, Lea JP, Patzer RE. Wilk AS, et al. Am J Kidney Dis. 2022 Jul;80(1):9-19. doi: 10.1053/j.ajkd.2021.12.012. Epub 2022 Feb 22. Am J Kidney Dis. 2022. PMID: 35217093 Free PMC article. - Relationships of race and ethnicity to progression of kidney dysfunction and clinical outcomes in patients with chronic kidney failure.
Lopes AA. Lopes AA. Adv Ren Replace Ther. 2004 Jan;11(1):14-23. doi: 10.1053/j.arrt.2003.10.006. Adv Ren Replace Ther. 2004. PMID: 14730535 Review. - Racial disparities in renal replacement therapy.
Gadegbeku C, Freeman M, Agodoa L. Gadegbeku C, et al. J Natl Med Assoc. 2002 Aug;94(8 Suppl):45S-54S. J Natl Med Assoc. 2002. PMID: 12152912 Free PMC article. Review.
Cited by
- Laboratory-based inequity in thrombosis and hemostasis: review of the evidence.
Merz LE, Siad FM, Creary M, Sholzberg M, Weyand AC. Merz LE, et al. Res Pract Thromb Haemost. 2023 Mar 15;7(2):100117. doi: 10.1016/j.rpth.2023.100117. eCollection 2023 Feb. Res Pract Thromb Haemost. 2023. PMID: 37063772 Free PMC article. Review. - Polycythemia in dogs with chronic hypoxic pulmonary disease.
Holopainen S, Laurila HP, Lappalainen AK, Rajamäki MM, Viitanen SJ. Holopainen S, et al. J Vet Intern Med. 2022 Jul;36(4):1202-1210. doi: 10.1111/jvim.16466. Epub 2022 Jun 14. J Vet Intern Med. 2022. PMID: 35702817 Free PMC article. - Racial/Ethnic Disparities in Atrial Fibrillation Treatment and Outcomes among Dialysis Patients in the United States.
Waddy SP, Solomon AJ, Becerra AZ, Ward JB, Chan KE, Fwu CW, Norton JM, Eggers PW, Abbott KC, Kimmel PL. Waddy SP, et al. J Am Soc Nephrol. 2020 Mar;31(3):637-649. doi: 10.1681/ASN.2019050543. Epub 2020 Feb 20. J Am Soc Nephrol. 2020. PMID: 32079604 Free PMC article. - Physiological and psychosocial stressors among hemodialysis patients in the Buea Regional Hospital, Cameroon.
Tchape ODM, Tchapoga YB, Atuhaire C, Priebe G, Cumber SN. Tchape ODM, et al. Pan Afr Med J. 2018 May 18;30:49. doi: 10.11604/pamj.2018.30.49.15180. eCollection 2018. Pan Afr Med J. 2018. PMID: 30197740 Free PMC article. - Racial and Ethnic Disparities in Survival of Children with ESRD.
Ku E, McCulloch CE, Grimes BA, Johansen KL. Ku E, et al. J Am Soc Nephrol. 2017 May;28(5):1584-1591. doi: 10.1681/ASN.2016060706. Epub 2016 Dec 29. J Am Soc Nephrol. 2017. PMID: 28034898 Free PMC article.
References
- Semin Nephrol. 2000 Jul;20(4):335-44 - PubMed
- J Am Soc Nephrol. 2006 Dec;17(12):3497-502 - PubMed
- N Engl J Med. 2000 Nov 23;343(21):1537-44, 2 p preceding 1537 - PubMed
- J Am Soc Nephrol. 2000 Feb;11(2):335-342 - PubMed
- J Am Coll Cardiol. 2002 Jul 3;40(1):27-33 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical